Skip to main content
. 2020 Feb 25;66(1):247–256. doi: 10.1007/s10620-020-06164-y

Table 1.

Characteristics of the study sample, by the presence of infection

Exposure No infection on admission
(n = 894)
Infection on admission
(n = 218)
p value
Age (years) 56 (10.6) 55 (9.7) 0.66
Sex (women) 287 (32%) 78 (36%) 0.47
Race/ethnicity 0.05
 White/Caucasian (non-Hispanic) 373 (77%) 110 (23%)
 African-American/black 248 (81%) 60 (19%)
 Hispanic/Latino 176 (83%) 35 (17%)
 Asian 29 (94%) 2 (6%)
 Other/unknown 68 (86%) 11 (14%)
Household income in US Dollars $43,532 ($21,021) $42,298 ($29,826) 0.40
Insurance provider 0.008
 Public (Medicare/Medicaid/County) 647 (78%) 178 (22%)
 Commercial 38 (76%) 12 (24%)
 Self-insured 159 (88%) 22 (12%)
 Other 50 (89%) 6 (11%)
Charlson comorbidity index 3 (1) 4 (2) 0.018
Diabetes 202 (84%) 39 (16%) 0.14
Body mass index (kg/m2) 27.7 (7.4) 27.5 (7.9) 0.96
Location pre-admission 0.37
 Skilled nursing facility 21 (72%) 8 (28%)
 Home 821 (81%) 194 (19%)
 Other 52 (76%) 16 (24%)
Model for End-Stage Liver Disease score with sodium (MELD–Na) 15.8 (9.4) 19.6 (10.4) < 0.001
Etiology of liver disease 0.68
 Alcohol only 360 (81%) 83 (19%)
 Viral hepatitis only 161 (80%) 41 (20%)
 Alcohol and viral hepatitis 245 (79%) 66 (21%)
 Nonalcoholic fatty liver disease 32 (76%) 10 (24%)
 Other etiologies 96 (84%) 18 (16%)
History of spontaneous bacterial peritonitis (SBP) 16 (57%) 12 (43%) 0.004
Alcohol use within 3 months 0.19
 0–2 drinks/day 520 (79%) 140 (21%)
  > 2 drinks/day 291 (84%) 54 (16%)
Pre-admission proton-pump inhibitor 310 (80%) 78 (20%) 0.88
Pre-admission antibiotic use for SBP prophylaxis or hepatic encephalopathy (excluding rifaximin) 21 (82%) 7 (18%) 0.86

Mean (standard deviation, SD) for normally distributed continuous parameters, median (interquartile range) for skewed continuous parameters, frequency (%) for categorical parameters

Bold values indicate statistically significant associations (p < 0.05 after adjustment for multiple comparisons via Benjamini–Hochberg method)